FT
LGND icon

Fiduciary Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Fiduciary Trust’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Buy
2,471
+144
+6% +$33.9K 0.01% 481
2026
Q1 		$465K Buy
2,327
+184
+9% +$36.4K 0.01% 589
2025
Q4 		$405K Buy
2,143
+445
+26% +$85.5K ﹤0.01% 629
2025
Q3 		$301K Buy
+1,698
New +$252K ﹤0.01% 708

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fiduciary Trust's LGND Position: Q2 2026 in Review

Fiduciary Trust increased its Ligand Pharmaceuticals (LGND) stake by 6.2% in Q2 2026, buying an estimated $33.9K and bringing the position to 2,471 shares worth $781K. The position accounts for 0.01% of the portfolio, ranked #481.

Fiduciary Trust first reported a position in LGND in Q3 2025 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Fiduciary Trust held 2,471 shares of Ligand Pharmaceuticals worth $781K as of Q2 2026.
  • Fiduciary Trust bought 144 Ligand Pharmaceuticals shares in Q2 2026, an estimated $33.9K.
  • Ligand Pharmaceuticals made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #481 holding.
  • Fiduciary Trust first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.